Clinical trial · Observational
Analysis of Metabonomics for Pleural Effusion
Metabonomics for Distinguishing Between Benign and Malignant Pleural Effusion and Assessing the Prognosis of Lung Cancer Patients With Malignant Pleural Effusion
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a multicenter retrospective study that collected diagnostic information of patients with pleural effusion. The overall survival (OS) time of malignant patients was followed up, defined as the time from diagnosis to death. Clinical data and residual pleural effusion specimens were collected from patients. Metabonomics was utilized to differentiate between benign and malignant pleural effusion and to evaluate the prognosis of lung cancer patients with malignant pleural effusion.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pleural Diseases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Detection of pleural effusion | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- benign pleural effusion
- description
- Patients with benign pleural effusion.
- interventionNames
- Other: Detection of pleural effusion
- label
- malignant pleural effusion patients with bad prognosis
- description
- The OS time of malignant pleural effusion patients is\<1 year.
- interventionNames
- Other: Detection of pleural effusion
- label
- malignant pleural effusion patients with good prognosis
- description
- The OS time of malignant pleural effusion patients is ≥1 year.
- interventionNames
- Other: Detection of pleural effusion
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * 18 Years to 80 Years; detection of pleural effusion by chest computed tomography, radiography, or ultrasonography; pathologically confirmed lung cancer in pleural effusion. Exclusion Criteria: * pleural effusion not caused by lung cancer or of unknown origin; other concurrent malignant diseases; incomplete information; lack of any follow-up data.
References
Publications (0)
Data not yet available